The most defensible rationale for oral BPC-157 is local action in the digestive tract itself
GIP receptor activation adds something unique
The SSA hired about 59,600 people in 2023, but high attrition and reduced hiring in 2024 largely offset those gains
Regulatory restrictions make many of these compounds hard to obtain, particularly in the United States
With consistent use, you will notice a reduction in hyperpigmentation, a smoother texture, and a more youthful appearance
At minimum: Outcomes Weight trend (weekly average) Waist circumference Body composition if available (DEXA, BIA with consistency) Strength markers (basic lifts, grip strength, functional tests) Safety Blood pressure + resting HR A1c and fasting glucose (more often if diabetes) CMP (liver/kidney) Lipids (periodic) If manipulating GH/IGF-1 signaling: IGF-1 (and clinical context matters) Stop criteria Persistent tachycardia, edema, severe fatigue, worsening glycemia, abnormal labs, or new symptoms you cant explain The what to ask your clinic questions (high signal, low fluff) If a clinic recommends a peptide stack, ask: What is the problem were solving, in one sentence
